George L Sing is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 26,272 shares of REGN, which is worth approximately $19.5 Million. The most recent transaction as insider was on Aug 12, 2021, when has been sold 1,000 shares (Common Stock) at a price of $611.0 per share, resulting in proceeds of $611,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.3K
4.37% 3M change
0.22% 12M change
Total Value Held $19.5 Million

GEORGE L SING Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2021
SELL
Open market or private sale
$611,000 $611.0 p/Share
1,000 Reduced 2.17%
45,063 Common Stock
Aug 11 2021
SELL
Open market or private sale
$1,241,000 $620.5 p/Share
2,000 Reduced 4.16%
46,063 Common Stock
Aug 10 2021
SELL
Open market or private sale
$1,596,400 $614.0 p/Share
2,600 Reduced 5.13%
48,063 Common Stock
Aug 06 2021
SELL
Open market or private sale
$2,445,320 $611.33 p/Share
4,000 Reduced 7.32%
50,663 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
248 Added 0.45%
54,663 Common Stock
GLS

George L Sing

Director
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN